Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nina Elonen"'
Autor:
FinnDiane Study Group, Lena M Thorn, Per-Henrik Groop, Valma Harjutsalo, Nina Elonen, Anni Ylinen, Fanny Jansson Sigfrids, Patrik Smidtslund
Objective: To study the prognosis after a first-ever myocardial infarction (MI) in type 1 diabetes, as well as how different MI- and diabetes-related factors affect the prognosis and risk of secondary cardiovascular events. Research Design and Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::252ced85940f33d95c41b87fea3e437a
https://doi.org/10.2337/figshare.21396999.v1
https://doi.org/10.2337/figshare.21396999.v1
Autor:
Lena M. Thorn, Carol Forsblom, Johan Wadén, Per-Henrik Groop, Nina Elonen, Valma Harjutsalo, Markku Saraheimo, Heikki O. Tikkanen, Heidi Tikkanen-Dolenc
Publikováno v:
Diabetes Care. 40:1727-1732
OBJECTIVE The aims of the study were to assess how baseline leisure-time physical activity (LTPA) and its exercise components intensity, duration, and frequency are associated with all-cause and cardiovascular mortality in patients with type 1 diabet
Autor:
Daniel Gordin, Jukka Putaala, Valma Harjutsalo, Lena M. Thorn, Nina Elonen, Stefanie Hägg-Holmberg, Turgut Tatlisumak, Carol Forsblom, Per-Henrik Groop, Ron Liebkind
Publikováno v:
Diabetes Care. 40:1394-1400
OBJECTIVE Although patients with type 1 diabetes have a poor prognosis after a stroke, predictors of survival after an incident stroke in these patients are poorly studied. RESEARCH DESIGN AND METHODS In this observational study, a total of 144 patie
Autor:
Johan Wadén, Per-Henrik Groop, Aila J. Ahola, Fanny J. Jansson, Carol Forsblom, Valma Harjutsalo, Markku Saraheimo, Nina Elonen, Lena M. Thorn
Aims/hypothesis Our aim was to assess regression of albuminuria and its clinical consequences in type 1 diabetes. Methods The analysis included 3642 participants from the Finnish Diabetic Nephropathy (FinnDiane) Study with a 24 h urine sample and a h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31c5d30bf1437015387aa2b5f701a8d
http://hdl.handle.net/10138/300778
http://hdl.handle.net/10138/300778
Autor:
Nina Elonen, Angelika Bierhaus, Daniel Gordin, Per-Henrik Groop, Valma Harjusalo, Nicolae Mircea Panduru, Carol Forsblom, Markku Saraheimo, Per M. Humpert, Lena M. Thorn
Publikováno v:
Diabetologia. 60(9)
In type 1 diabetes, cardiovascular disease (CVD) and diabetic nephropathy progress in parallel, thereby potentiating the risk of premature death during their development. Since urinary liver-type fatty acid binding protein (L-FABP) predicts the progr